Mergers and Acquisitions in India¡¯s Pharmaceutical Sector
A merger and acquisition (M&A) refers an arrangement whereby the assets, liabilities and business of two companies become vested in or under the control of one company. M&A is a tool for expanding business or get around different laws or regulations such as tax laws or monopoly regulations. This paper aims to examine the impact of M&A on the financial performance of the companies involved in pharmaceutical industry. For this purpose, a case study of GlaxoSmithKline has been selected. The pre and post-merger performances, in terms of variables like sales, net earnings, debt equity ratio and return on equity ratio of the company, have been analyzed by applying independent sample t test as a main statistical tool.
Volume (Year): 6 (2014)
Issue (Month): 1 (March)
|Contact details of provider:|| Postal: |
When requesting a correction, please mention this item's handle: RePEc:oul:tncr09:v:6:y:2014:i:1:p:86-100. See general information about how to correct material in RePEc.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Denny Liao)The email address of this maintainer does not seem to be valid anymore. Please ask Denny Liao to update the entry or send us the correct address or (Jen Ma)
If references are entirely missing, you can add them using this form.